FIELD: organic chemistry, steroids. SUBSTANCE: product: 3-hydroxy-1,3,5-triene-17-hydrazone of the formula showing hormonal and antitumor activity. EFFECT: improved method of synthesis.
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL PREPARATION POSSESSING ANTITUMOR ACTIVITY | 1988 |
|
RU2039560C1 |
A-NOR-3-AZA-CHLOROACETYL-5B-CHOLESTANE DISPLAYING ANTITUMOR ACTIVITY | 0 |
|
SU1072447A1 |
3-OR-DI-(2-CHLOROETHYL)-AMINO-CONTAINING II α-ACYL-(HYDR)- -OXYSTEROIDS SHOWING ANTITUMOR ACTIVITY | 1998 |
|
RU2139292C1 |
3-O-SULFAMOILOXY-6-OXA-7Β-METHYL-D-HOMO-8Α-ESTRA-1,3,5(10)-TRIEN-17Α-ONE APPLICATION FOR THE BREAST CANCER TREATMENT, INCLUDING THE TRIPLE NEGATIVE FORM, AND ITS PRODUCTION METHOD | 2018 |
|
RU2679625C1 |
11-DESOXY-17ALPHA-OXY-21-/H-DI(2-CHLORETHYL) AMINOPHENYLACETATE/-CORTICOSTERONE SHOWING ANTITUMOR ACTIVITY | 0 |
|
SU1249022A1 |
AGENT ELICITING ANTITUMOR EFFECT | 2003 |
|
RU2254139C1 |
HYDROXYMATAIRESINOL IN PREVENTING THE CANCER | 2000 |
|
RU2241453C2 |
MEDICAL APPLICATIONS SELECTIVE ESTROGEN RECEPTOR MODULATORS IN COMBINATION WITH STEROID SEX HORMONE PRECURSORS | 1999 |
|
RU2246947C2 |
METHOD FOR REDUCING RISK TO ACQUIRE MAMMARY GLAND CARCINOMA | 1992 |
|
RU2067001C1 |
USE OF 3-O-SULFAMOYLOXY-7Β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE FOR THE TREATMENT OF BREAST CANCER, INCLUDING A TRIPLE NEGATIVE FORM | 2018 |
|
RU2678845C1 |
Authors
Dates
1996-10-27—Published
1984-11-23—Filed